Gilead Sciences
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 4,750 $17.16 $81,524
Sale
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 4,750 $76.17 $361,784
Option
ALTON GREGG H officer: Chief Patient Officer
 Non-Qualified Stock Option (right to buy) 10,100 $15.38 $155,368
Option
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 10,100 $15.38 $155,368
Sale
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 15,100 $75 $1,132,500
Option
BERG PAUL director
 Common Stock 6,500 $4.78 $31,076
Sale
BERG PAUL director
 Common Stock 6,500 $68.83 $447,402
Option
BERG PAUL director
 Non-Qualified Stock Option (right to buy) 6,500 $4.78 $31,076
Sale
MARTIN JOHN C director
 Common Stock 35,000 $70.27 $2,459,415
Option
MARTIN JOHN C director
 Common Stock 35,000 $2.86 $100,065
Option
MARTIN JOHN C director
 Non-Qualified Stock Option (right to buy) 35,000 $2.86 $100,065
Option
DENNY JAMES M director
 Non-Qualified Stock Option (right to buy) 40,000 $5.95 $237,960
Option
DENNY JAMES M director
 Common Stock 40,000 $5.68 $227,080
Sale
DENNY JAMES M director
 Common Stock 30,000 $70.58 $2,117,340
Option
ALTON GREGG H officer: Chief Patient Officer
 Non-Qualified Stock Option (right to buy) 4,750 $13.6 $64,614
Sale
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 4,750 $70.21 $333,497
Option
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 4,750 $13.6 $64,614
Option
MEYERS JAMES R officer: EVP Worldwide Commerci..
 Common Stock 6,000 $7.08 $42,468
Option
MEYERS JAMES R officer: EVP Worldwide Commerci..
 Incentive Stock Option (right to buy) 6,000 $7.08 $42,468
Sale
MEYERS JAMES R officer: EVP Worldwide Commerci..
 Common Stock 6,000 $71.35 $428,088
Option
TOOLE JOHN J officer: SVP, Clinical Research
 Common Stock 20,000 $13.6 $272,060
Option
TOOLE JOHN J officer: SVP, Clinical Research
 Non-qualified stock Option (right-to-buy) 20,000 $13.6 $272,060
Sale
TOOLE JOHN J officer: SVP, Clinical Research
 Common Stock 20,000 $73.27 $1,465,460
Sale
MILLIGAN JOHN F director, officer: President an..
 Common Stock 20,000 $73.63 $1,472,620
Option
MILLIGAN JOHN F director, officer: President an..
 Non-Qualified Stock Option (right to buy) 20,000 $8.6 $172,080
Option
MILLIGAN JOHN F director, officer: President an..
 Common Stock 20,000 $8.6 $172,080
Sale
YANG TAIYIN officer: SVP, Pharm Dev & Mfg
 Common Stock 20,000 $73.74 $1,474,840
Option
MOORE GORDON EARLE director
 Common Stock 16,000 $3.28 $52,496
Option
MOORE GORDON EARLE director
 Non-Qualified Stock Option (right to buy) 16,000 $3.28 $52,496
Option
YOUNG KEVIN officer: Chief Operating Officer
 Non-Qualified Stock Option (right to buy) 30,000 $33.69 $1,010,550
Option
YOUNG KEVIN officer: Chief Operating Officer
 Common Stock 30,000 $33.69 $1,010,550
Sale
YOUNG KEVIN officer: Chief Operating Officer
 Common Stock 30,000 $72.3 $2,168,880
Option
LEE WILLIAM A officer: SVP, Research
 Common Stock 32,000 $7.41 $236,992
Option
LEE WILLIAM A officer: SVP, Research
 Non-Qualified Stock Option (right to buy) 32,000 $7.41 $236,992
Sale
LEE WILLIAM A officer: SVP, Research
 Common Stock 32,000 $72 $2,303,904
Sale
LEE WILLIAM A officer: SVP, Research
 Common Stock 20,000 $72.03 $1,440,660
Option
LEE WILLIAM A officer: SVP, Research
 Common Stock 20,000 $7.41 $148,120
Option
LEE WILLIAM A officer: SVP, Research
 Non-Qualified Stock Option (right to buy) 20,000 $7.41 $148,120
Option
MARTIN JOHN C director
 Common Stock 35,000 $2.86 $100,065
Option
MARTIN JOHN C director
 Non-Qualified Stock Option (right to buy) 35,000 $2.86 $100,065
Sale
MARTIN JOHN C director
 Common Stock 35,000 $70.78 $2,477,125
Sale
BISCHOFBERGER NORBERT W officer: EVP, R&D and CSO
 Common Stock 133,920 $71.27 $9,544,478
Option
BISCHOFBERGER NORBERT W officer: EVP, R&D and CSO
 Common Stock 140,000 $16.44 $2,301,320
Option
BISCHOFBERGER NORBERT W officer: EVP, R&D and CSO
 Incentive Stock Option (right to buy) 6,080 $16.44 $99,943
Sale
YANG TAIYIN officer: SVP, Pharm Dev & Mfg
 Common Stock 20,000 $70.23 $1,404,600
Sale
DAVIGNON ETIENNE director
 Common Stock 19,000 $69.95 $1,329,069
Option
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 20,650 $13.6 $280,902
Sale
ALTON GREGG H officer: Chief Patient Officer
 Common Stock 20,650 $70.38 $1,453,244
Option
ALTON GREGG H officer: Chief Patient Officer
 Non-Qualified Stock Option (right-to-buy) 20,650 $13.6 $280,902
Sale
BERG PAUL director
 Common Stock 6,500 $64.42 $418,711

Showing 2550 to 2600 of 3053 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: